Drugs / Anti-5T4 CAR-raNK Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05137275 | Nov 2021 → Apr 2023 | — | Shanghai East Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-5T4 CAR-raNK Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05137275 ↗ |
| Modality | Cell therapy | “conjugated antibody redirecting ready-to-use allogeneic NK (CAR-raNK) cells” NCT05137275 ↗ |
| Route | Intravenous | “intravenous infusion is performed” NCT05137275 ↗ |